# MILESTONE PHARMACEUTICALS IN (MIST)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/MIST/

- Reporting holders: 2
- Reported value: $1.1M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [RVW Wealth, LLC](https://holderbook.com/funds/1756543-rvw-wealth-llc/) | $994.0K | 1,148,260 | 0.1% | 1 |
| [Valeo Financial Advisors, LLC](https://holderbook.com/funds/1722641-valeo-financial-advisors-llc/) | $127.0K | 146,699 | 0.0% | 17 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $1.1M |
| Q2 2026 | 80 | $69.1M |
| Q1 2026 | 87 | $48.4M |
| Q4 2025 | 80 | $91.0M |
| Q3 2025 | 61 | $69.3M |
| Q2 2025 | 45 | $23.8M |
| Q1 2025 | 45 | $9.8M |
| Q4 2024 | 47 | $58.4M |
| Q3 2024 | 42 | $43.6M |
| Q2 2024 | 42 | $42.3M |
| Q1 2024 | 43 | $59.4M |
| Q4 2023 | 40 | $31.5M |